23.96 USD
↘ 0.03 (0.13%)PRE MARKET (AS OF 07:31 PM EDT)
Surrozen, Inc. Common
SRZNNASDAQ • USD
Market: OPEN
SRZN is currently priced at $23.96. SRZN shows a split signal: technical indicators suggest "Strong Buy" while underlying fundamentals indicate "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, exceptional Return on Equity (160.2%) and a bullish Golden Cross on the moving averages. On the valuation front, SRZN trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Aug 21, 2026.
Open?$23.73
High?$24.38
Low?$23.50
Prev. Close?$23.99
Volume?141.4K
Avg. Volume?249.3K
VWAP?$23.83
Rel. Volume?0.57x
Bid / Ask
Bid?$20.57 × 100
Ask?$66.54 × 100
Spread?$45.97
Midpoint?$43.56
Valuation & Ratios
Market Cap?282.0M
Shares Out?11.6M
Float?4.1M
Float %?47.9%
P/E Ratio?N/A
P/B Ratio?-1.29
EPS?-$29.80
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).
Employees
44
Market Cap
282.0M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2021-08-12
Address
171 OYSTER POINT BLVD
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-475-2820
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-475-2820
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?12
Z-Score?0
Momentum?50
Short Sent.?33
Piotroski F-Score?2/9Weak
Altman Z-Score?-6.94Distress
Confidence?63%Moderate
Short InterestSqueeze Risk
Short % of Float?28.02%Squeeze Risk
Short Interest?1.2M
Days to Cover?4.1
Free Float4.1M
Avg Daily Volume283.1K
Settlement Date2026-07-31
Financial Health
Current Ratio?12.14Strong
Quick Ratio?12.14Strong
Cash Ratio?11.32Strong
Debt/Equity?-0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-1.29CHEAP▾
S&P97
P/S?24.50HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-4.1CHEAP▾
S&P97
EV/Sales?15.63HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?160.2%STRONG▾
Peers50
S&P97
ROA?-303.0%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-34984000
Enterprise Value?$179.9M
Fundamentals ratios updated end of day